1. Home
  2. RIO vs NVS Comparison

RIO vs NVS Comparison

Compare RIO & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rio Tinto Plc

RIO

Rio Tinto Plc

HOLD

Current Price

$100.13

Market Cap

173.1B

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$147.34

Market Cap

286.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIO
NVS
Founded
1873
1895
Country
United Kingdom
Switzerland
Employees
61230
75267
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.1B
286.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RIO
NVS
Price
$100.13
$147.34
Analyst Decision
Buy
Hold
Analyst Count
6
5
Target Price
$88.50
$144.00
AVG Volume (30 Days)
2.5M
1.6M
Earning Date
02-19-2026
04-28-2026
Dividend Yield
4.14%
2.16%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.99
$2.30
Revenue Next Year
$2.64
$5.27
P/E Ratio
$15.76
$23.13
Revenue Growth
N/A
N/A
52 Week Low
$55.64
$112.34
52 Week High
$112.58
$170.46

Technical Indicators

Market Signals
Indicator
RIO
NVS
Relative Strength Index (RSI) 43.21 45.57
Support Level $98.02 $143.27
Resistance Level $100.90 $154.57
Average True Range (ATR) 2.25 2.27
MACD -0.53 0.09
Stochastic Oscillator 12.20 40.56

Price Performance

Historical Comparison
RIO
NVS

About RIO Rio Tinto Plc

Rio Tinto is a global diversified miner. Iron ore is its major commodity, with lesser contributions from copper and aluminum. Lithium, diamonds, gold, and industrial minerals are more minor contributors. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: